THERESA WINTON: Open Payments
NPI 1073860383 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 33 payments from 11 companies in 2025. Trend: 2023 $235 · 2024 $645 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 7 | $180 |
| Alkermes, Inc. | 5 | $108 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| ABBVIE INC. | 3 | $75 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Almatica Pharma LLC | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: REXULTI, LYBALVI, VRAYLAR, INGREZZA, AUSTEDO XR, FANAPT, LOREEV XR, Sunosi.
Industry payments across FL — which companies pay providers there.
